WACHTER ERIC PHD

CIK 00011242611 companyKNOXVILLE, TN

SEC Profile

Transactions

Companies

Filings

CIK

0001124261

Recent Transactions

50 trades

Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2024-12-02+2,138,548→ 2,138,548 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Secured Convertible Promissory Notes due 2021
2021-06-20→ 0 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Series D-1 Convertible Preferred Stock
2021-06-20+1,393,276→ 1,393,276 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
8% Secured Convertible Promissory Notes due 2021
2021-06-17
Exercise Out-of-Money
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock Warrants (right to buy)
2016-03-29−306,947→ 359,719 total
Exercise Out-of-Money
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock Warrants (right to buy)
2016-03-29+306,947→ 306,947 total
Exercise Out-of-Money
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2016-03-29$1.00/sh+200,947→ 5,714,183 total
Exercise Out-of-Money
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2016-03-29$1.00/sh+106,000→ 930,248 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Employee Stock Option (right to buy)
2015-12-21−120,000→ 120,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2015-12-21$1.02/sh+120,000→ 5,513,236 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Option (right to buy)
2015-12-09+400,000→ 400,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2015-01-24$1.02/sh+185,000→ 824,248 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Employee Stock Option (right to buy)
2015-01-24−185,000→ 800,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Employee Stock Option (Right to buy)
2014-03-20−14,248→ 0 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Employee Stock Option (Right to buy)
2014-03-20−25,000→ 0 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2014-03-20$0.75/sh+14,248→ 5,432,484 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Employee Stock Option (Right to buy)
2014-03-20−600,000→ 0 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2014-03-20$0.93/sh+600,000→ 6,032,484 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2014-03-20$0.95/sh+25,000→ 5,418,236 total
Purchase
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2012-11-16+666,666→ 5,393,236 total
Purchase
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock Warrants (right to buy)
2012-11-16+666,666→ 666,666 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2011-12-05$0.75/sh+100,000→ 4,726,570 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2011-12-05−100,000→ 14,248 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2011-12-01+100,000→ 600,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2011-12-01$0.93/sh+100,000→ 4,626,570 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2011-11-23$0.93/sh+100,000→ 4,526,570 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2011-11-23−100,000→ 700,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2011-10-19−100,000→ 800,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2011-10-19$0.93/sh+100,000→ 4,426,570 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2011-09-07−100,000→ 900,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2011-09-07$0.93/sh+100,000→ 4,326,570 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2011-09-06+1,000,000→ 1,000,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2011-07-29$1.00/sh+100,000→ 4,226,570 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2011-07-29−100,000→ 0 total
Award
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (right to buy)
2011-07-06+50,000→ 50,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2011-05-03$1.00/sh+100,000→ 4,126,570 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2011-05-03−100,000→ 100,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2011-04-20−100,000→ 200,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2011-04-20$1.00/sh+100,000→ 4,026,570 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2011-04-12−50,000→ 0 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2011-04-12$1.00/sh+150,000→ 3,926,570 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2011-04-12−100,000→ 300,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2011-02-07$0.75/sh+8,333→ 3,776,570 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2011-02-07+8,333→ 114,248 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options - Right to Buy
2011-02-03−125,000→ 122,581 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2011-02-03$0.75/sh+125,000→ 3,768,237 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2010-12-29$1.00/sh+400,000→ 3,643,237 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Options (Right to Buy)
2010-12-29−400,000→ 400,000 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Common Stock
2010-11-19$1.00/sh+100,000→ 3,243,237 total
Exercise/Conversion
PROVECTUS BIOPHARMACEUTICALS, INC.$PVCT
Stock Option (Right to Buy)
2010-11-19−100,000→ 800,000 total

Companies

PROVECTUS BIOPHARMACEUTICALS, INC.
Director, Vice President Pharmaceuticals
$PVCT

Recent Filings

Address

7327 OAK RIDGE HIGHWAY, SUITE A

KNOXVILLE, TN, 37931

View on SEC.gov